id	sid	eid	entity	type
admet-2338	1	1	neusilin us2	PERSON
admet-2338	1	2	https://doi.org/10.5599/admet.2338 687 admet & dmpk	ORG
admet-2338	1	3	12(4	CARDINAL
admet-2338	1	4	2024	CARDINAL
admet-2338	1	5	687	CARDINAL
admet-2338	1	6	issn	PERSON
admet-2338	1	7	1848-7718	DATE
admet-2338	1	8	neusilin us2	PERSON
admet-2338	1	9	bijoy kumar panda1	PERSON
admet-2338	1	10	sharad ghodake3	PERSON
admet-2338	1	11	ashwin j. mali3	PERSON
admet-2338	1	12	ravindra kamble3	PERSON
admet-2338	1	13	krishna institute of pharmacy	ORG
admet-2338	1	14	krishna vishwa vidyapeeth	PERSON
admet-2338	1	15	karad	GPE
admet-2338	1	16	maharashtra	GPE
admet-2338	1	17	india	GPE
admet-2338	1	18	2department	CARDINAL
admet-2338	1	19	goa college	ORG
admet-2338	1	20	goa university	ORG
admet-2338	1	21	panaji	GPE
admet-2338	1	22	goa,	ORG
admet-2338	1	23	3department	CARDINAL
admet-2338	1	24	poona college of pharmacy	ORG
admet-2338	1	25	vidyapeeth	PERSON
admet-2338	1	26	pune	GPE
admet-2338	1	27	maharashtra	GPE
admet-2338	1	28	india	GPE
admet-2338	2	1	+91-9881049010	DATE
admet-2338	2	2	march 29,	DATE
admet-2338	2	3	2024	DATE
admet-2338	2	4	july 23, 2024	DATE
admet-2338	2	5	august 9,2024	DATE
admet-2338	2	6	sorafenib tosylate	PERSON
admet-2338	5	1	sfnssd	ORG
admet-2338	5	2	neusilin us2	PERSON
admet-2338	6	1	32	CARDINAL
admet-2338	7	1	sfn	CARDINAL
admet-2338	7	2	more than 20-fold	CARDINAL
admet-2338	7	3	sfn	CARDINAL
admet-2338	8	1	ftir	LOC
admet-2338	8	2	sfn	ORG
admet-2338	10	1	sfn	CARDINAL
admet-2338	10	2	97.13	CARDINAL
admet-2338	10	3	29.93 %	PERCENT
admet-2338	10	4	1	CARDINAL
admet-2338	10	5	sfn	CARDINAL
admet-2338	10	6	2	CARDINAL
admet-2338	10	7	6.5-fold	CARDINAL
admet-2338	11	1	sfn	CARDINAL
admet-2338	12	1	2024	CARDINAL
admet-2338	15	1	1	CARDINAL
admet-2338	17	1	1	CARDINAL
admet-2338	19	1	bayer healthcare pharmaceuticals inc.	ORG
admet-2338	20	1	https://doi.org/10.5599/admet.2338 https://doi.org/10.5599/admet.2338 http://www.pub.iapchem.org/ojs/index.php/admet/index mailto:kravi_73@rediffmail.com	PERSON
admet-2338	21	1	b. kumar	PERSON
admet-2338	21	2	al. admet & dmpk	ORG
admet-2338	21	3	12(4	CARDINAL
admet-2338	21	4	2024	CARDINAL
admet-2338	21	5	687	CARDINAL
admet-2338	21	6	4	CARDINAL
admet-2338	21	7	38 to 49 %	PERCENT
admet-2338	21	8	2	CARDINAL
admet-2338	23	1	5	CARDINAL
admet-2338	26	1	1	CARDINAL
admet-2338	28	1	6-8	CARDINAL
admet-2338	29	1	ssd	ORG
admet-2338	29	2	neusilin®	PERSON
admet-2338	29	3	aerosil®	ORG
admet-2338	29	4	200	CARDINAL
admet-2338	30	1	neusilin	PERSON
admet-2338	34	1	9	CARDINAL
admet-2338	35	1	10-12	CARDINAL
admet-2338	36	1	13	CARDINAL
admet-2338	38	1	sfn	CARDINAL
admet-2338	39	1	32	CARDINAL
admet-2338	39	2	11	CARDINAL
admet-2338	40	1	17,18	CARDINAL
admet-2338	41	1	wistar rats	ORG
admet-2338	43	1	12(4	CARDINAL
admet-2338	43	2	2024	CARDINAL
admet-2338	43	3	687-702	QUANTITY
admet-2338	43	4	neusilin us2	PERSON
admet-2338	43	5	https://doi.org/10.5599/admet.2338 689	PRODUCT
admet-2338	43	6	cipla ltd	ORG
admet-2338	43	7	mumbai	GPE
admet-2338	43	8	india	GPE
admet-2338	44	1	neusilin®	PERSON
admet-2338	44	2	us2(≥99.9 %	PERCENT
admet-2338	44	3	fuji chemical industries co., ltd	ORG
admet-2338	44	4	japan	GPE
admet-2338	45	1	99 %	PERCENT
admet-2338	45	2	merck specialties co ltd	ORG
admet-2338	45	3	mumbai	GPE
admet-2338	45	4	india	GPE
admet-2338	46	1	hplc grade methanol (	ORG
admet-2338	46	2	india	GPE
admet-2338	47	1	millipore water	PERSON
admet-2338	48	1	2 ml	QUANTITY
admet-2338	48	2	0.1n	CARDINAL
admet-2338	48	3	6.8	CARDINAL
admet-2338	48	4	24 hours	TIME
admet-2338	49	1	0.45	CARDINAL
admet-2338	49	2	265	CARDINAL
admet-2338	50	1	14	CARDINAL
admet-2338	51	1	sfn	CARDINAL
admet-2338	52	1	three	CARDINAL
admet-2338	52	2	aerosil 200	PERSON
admet-2338	52	3	100	CARDINAL
admet-2338	53	1	0.2 ml	QUANTITY
admet-2338	53	2	1 ml	QUANTITY
admet-2338	53	3	1:2	CARDINAL
admet-2338	54	1	60 °	QUANTITY
admet-2338	57	1	1 ml	QUANTITY
admet-2338	57	2	1 %	PERCENT
admet-2338	57	3	407	CARDINAL
admet-2338	57	4	188	CARDINAL
admet-2338	57	5	50/13	CARDINAL
admet-2338	58	1	19	CARDINAL
admet-2338	59	1	24 hours	TIME
admet-2338	59	2	15 min at 15000	TIME
admet-2338	60	1	265	CARDINAL
admet-2338	62	1	ssd-sfn	ORG
admet-2338	63	1	32	CARDINAL
admet-2338	63	2	11	CARDINAL
admet-2338	63	3	1	CARDINAL
admet-2338	64	1	20,21	CARDINAL
admet-2338	65	1	nine	CARDINAL
admet-2338	65	2	11	CARDINAL
admet-2338	66	1	50 mg	QUANTITY
admet-2338	67	1	1	CARDINAL
admet-2338	69	1	1	CARDINAL
admet-2338	70	1	0.25 ml	QUANTITY
admet-2338	70	2	0.5 ml	QUANTITY
admet-2338	70	3	10 mins	TIME
admet-2338	71	1	another 20 minutes	TIME
admet-2338	72	1	sfn	CARDINAL
admet-2338	72	2	60 °	QUANTITY
admet-2338	72	3	6 hours	TIME
admet-2338	73	1	https://doi.org/10.5599/admet.2338 b. kumar	PERSON
admet-2338	73	2	al. admet & dmpk	ORG
admet-2338	73	3	12(4	CARDINAL
admet-2338	73	4	2024	CARDINAL
admet-2338	73	5	687	CARDINAL
admet-2338	73	6	690	CARDINAL
admet-2338	73	7	1	CARDINAL
admet-2338	73	8	32	CARDINAL
admet-2338	74	1	sfn	CARDINAL
admet-2338	74	2	100 150 200	CARDINAL
admet-2338	74	3	sfn	CARDINAL
admet-2338	74	4	sfn	CARDINAL
admet-2338	76	1	265	CARDINAL
admet-2338	76	2	jasco	GPE
admet-2338	76	3	japan	GPE
admet-2338	76	4	14	CARDINAL
admet-2338	77	1	2 ml	QUANTITY
admet-2338	77	2	24 hours	TIME
admet-2338	78	1	0.45	CARDINAL
admet-2338	78	2	jasco	GPE
admet-2338	78	3	japan	GPE
admet-2338	78	4	265	CARDINAL
admet-2338	79	1	15	CARDINAL
admet-2338	82	1	265	CARDINAL
admet-2338	82	2	jasco	GPE
admet-2338	82	3	japan	GPE
admet-2338	83	1	the jasco v4100 ftir (tokyo	ORG
admet-2338	83	2	japan	GPE
admet-2338	84	1	kbr	PERSON
admet-2338	84	2	4000	CARDINAL
admet-2338	84	3	400	CARDINAL
admet-2338	85	1	16	CARDINAL
admet-2338	86	1	philips	GPE
admet-2338	86	2	netherlands	GPE
admet-2338	86	3	30	CARDINAL
admet-2338	86	4	30 ma	QUANTITY
admet-2338	87	1	0.02626°	CARDINAL
admet-2338	87	2	2	CARDINAL
admet-2338	87	3	5	CARDINAL
admet-2338	88	1	18	CARDINAL
admet-2338	89	1	sfn	GPE
admet-2338	89	2	japan	GPE
admet-2338	90	1	about 24	CARDINAL
admet-2338	90	2	16	CARDINAL
admet-2338	91	1	mettler toledo dsc	ORG
admet-2338	91	2	821	CARDINAL
admet-2338	91	3	switzerland	GPE
admet-2338	92	1	3-5 mg	TIME
admet-2338	92	2	10 °	QUANTITY
admet-2338	92	3	50 ml/min	QUANTITY
admet-2338	93	1	40	CARDINAL
admet-2338	93	2	320 °	QUANTITY
admet-2338	94	1	18	CARDINAL
admet-2338	95	1	12(4	CARDINAL
admet-2338	95	2	2024	CARDINAL
admet-2338	95	3	687-702	QUANTITY
admet-2338	95	4	neusilin us2	PERSON
admet-2338	95	5	691	CARDINAL
admet-2338	95	6	100	CARDINAL
admet-2338	96	1	2	CARDINAL
admet-2338	99	1	120 °	QUANTITY
admet-2338	99	2	1 hour	TIME
admet-2338	102	1	carr	PERSON
admet-2338	102	2	hausner	PERSON
admet-2338	103	1	12 mm	QUANTITY
admet-2338	103	2	karnavati engineering ltd	ORG
admet-2338	104	1	2	CARDINAL
admet-2338	104	2	sfn	CARDINAL
admet-2338	104	3	sfn	CARDINAL
admet-2338	104	4	1 15 100 0.424 ±	QUANTITY
admet-2338	104	5	150	CARDINAL
admet-2338	105	1	±	CARDINAL
admet-2338	105	2	311e	CARDINAL
admet-2338	106	1	three	CARDINAL
admet-2338	107	1	vernier calliper	ORG
admet-2338	107	2	mitutoyo, usa	ORG
admet-2338	110	1	indian	NORP
admet-2338	110	2	37 °	QUANTITY
admet-2338	113	1	12	CARDINAL
admet-2338	113	2	roche	ORG
admet-2338	113	3	25	CARDINAL
admet-2338	113	4	4 minutes	TIME
admet-2338	114	1	wi	ORG
admet-2338	114	2	less than 1 %	PERCENT
admet-2338	115	1	20	CARDINAL
admet-2338	117	1	sfn	ORG
admet-2338	117	2	900 ml	QUANTITY
admet-2338	117	3	0.1	CARDINAL
admet-2338	117	4	37 ± 0.5 °	QUANTITY
admet-2338	117	5	75	CARDINAL
admet-2338	118	1	five millilitres	QUANTITY
admet-2338	119	1	three	CARDINAL
admet-2338	120	1	0.45	CARDINAL
admet-2338	120	2	sfn	CARDINAL
admet-2338	120	3	max 265	FAC
admet-2338	121	1	pcp disso v3	PERSON
admet-2338	121	2	pune	GPE
admet-2338	122	1	https://doi.org/10.5599/admet.2338 b. kumar	PERSON
admet-2338	122	2	al. admet & dmpk	ORG
admet-2338	122	3	12(4	CARDINAL
admet-2338	122	4	2024	CARDINAL
admet-2338	122	5	687	CARDINAL
admet-2338	123	1	uv-2075	GPE
admet-2338	123	2	japan	GPE
admet-2338	123	3	jasco borwin	PERSON
admet-2338	124	1	5 µm	DATE
admet-2338	124	2	250×4.6 mm	QUANTITY
admet-2338	124	3	germany	GPE
admet-2338	125	1	1 %	PERCENT
admet-2338	125	2	35:40:25	CARDINAL
admet-2338	125	3	1 ml/min	QUANTITY
admet-2338	125	4	20	CARDINAL
admet-2338	126	1	265	CARDINAL
admet-2338	127	1	5	CARDINAL
admet-2338	128	1	150	CARDINAL
admet-2338	128	2	150	CARDINAL
admet-2338	129	1	500	CARDINAL
admet-2338	129	2	4	CARDINAL
admet-2338	129	3	1	CARDINAL
admet-2338	129	4	20 min	DATE
admet-2338	130	1	15000	CARDINAL
admet-2338	130	2	4 °	QUANTITY
admet-2338	130	3	20 min	QUANTITY
admet-2338	131	1	0.2 μm	QUANTITY
admet-2338	131	2	14	CARDINAL
admet-2338	132	1	24	CARDINAL
admet-2338	132	2	wistar rats	ORG
admet-2338	132	3	200-220	QUANTITY
admet-2338	132	4	the national institute of biosciences,	ORG
admet-2338	132	5	1091	DATE
admet-2338	133	1	iaec	ORG
admet-2338	133	2	poona college of pharmacy	ORG
admet-2338	133	3	bharti vidyapeeth	PERSON
admet-2338	136	1	12	CARDINAL
admet-2338	139	1	12 hour	TIME
admet-2338	139	2	24 °	QUANTITY
admet-2338	139	3	55 %	PERCENT
admet-2338	140	1	16	CARDINAL
admet-2338	141	1	24	CARDINAL
admet-2338	141	2	two	CARDINAL
admet-2338	141	3	12	CARDINAL
admet-2338	142	1	20 mg/kg	QUANTITY
admet-2338	142	2	sfn	CARDINAL
admet-2338	143	1	16	CARDINAL
admet-2338	144	1	0.5 ml	QUANTITY
admet-2338	144	2	45 mg/kg	QUANTITY
admet-2338	144	3	0.5	CARDINAL
admet-2338	144	4	1	CARDINAL
admet-2338	144	5	2	DATE
admet-2338	144	6	4	DATE
admet-2338	144	7	8	DATE
admet-2338	144	8	12	DATE
admet-2338	144	9	24	DATE
admet-2338	144	10	6	CARDINAL
admet-2338	144	11	48-hour	TIME
admet-2338	145	1	10,000	CARDINAL
admet-2338	145	2	15 min	TIME
admet-2338	145	3	4 °	QUANTITY
admet-2338	147	1	half	CARDINAL
admet-2338	147	2	®	ORG
admet-2338	147	3	2.1	CARDINAL
admet-2338	147	4	pharsight co.	ORG
admet-2338	148	1	10,16	CARDINAL
admet-2338	149	1	one	CARDINAL
admet-2338	149	2	anova	ORG
admet-2338	150	1	0.05	CARDINAL
admet-2338	151	1	±	CARDINAL
admet-2338	154	1	2a	CARDINAL
admet-2338	154	2	0.0288 ± 0.0017 mg/ml	MONEY
admet-2338	154	3	12(4	CARDINAL
admet-2338	154	4	2024	CARDINAL
admet-2338	154	5	687-702	QUANTITY
admet-2338	154	6	neusilin us2	PERSON
admet-2338	154	7	https://doi.org/10.5599/admet.2338 693	PERSON
admet-2338	154	8	221.79 ± 45.26 mg	MONEY
admet-2338	155	1	22,23	CARDINAL
admet-2338	156	1	0.1	CARDINAL
admet-2338	156	2	hcl	PERSON
admet-2338	156	3	4.4	CARDINAL
admet-2338	156	4	6.8	CARDINAL
admet-2338	159	1	aerosil 200	ORG
admet-2338	159	2	100	CARDINAL
admet-2338	159	3	24	CARDINAL
admet-2338	160	1	2b	CARDINAL
admet-2338	160	2	0.1198 ± 0.014 mg/ml	MONEY
admet-2338	161	1	us	GPE
admet-2338	162	1	japanese	NORP
admet-2338	162	2	18,25	CARDINAL
admet-2338	166	1	sfn	ORG
admet-2338	166	2	1 %	PERCENT
admet-2338	166	3	poloxamer 407	ORG
admet-2338	166	4	188	CARDINAL
admet-2338	166	5	50/13	CARDINAL
admet-2338	167	1	2c	CARDINAL
admet-2338	167	2	1.7027 ± 0.1186 mg	MONEY
admet-2338	168	1	40	CARDINAL
admet-2338	168	2	26	CARDINAL
admet-2338	169	1	sfn	CARDINAL
admet-2338	170	1	2	CARDINAL
admet-2338	170	2	32	CARDINAL
admet-2338	170	3	11	CARDINAL
admet-2338	171	1	nine	CARDINAL
admet-2338	172	1	0.460	CARDINAL
admet-2338	173	1	2	CARDINAL
admet-2338	173	2	0.144389 + 0.007733x1 + 0.001737x2	DATE
admet-2338	173	3	2	CARDINAL
admet-2338	173	4	0.5846	CARDINAL
admet-2338	173	5	0.7309	CARDINAL
admet-2338	174	1	less than 0.0500	CARDINAL
admet-2338	174	2	11.86	CARDINAL
admet-2338	175	1	2	CARDINAL
admet-2338	175	2	3d	CARDINAL
admet-2338	175	3	3	CARDINAL
admet-2338	176	1	https://doi.org/10.5599/admet.2338 b. kumar	PERSON
admet-2338	176	2	al. admet & dmpk	ORG
admet-2338	176	3	12(4	CARDINAL
admet-2338	176	4	2024	CARDINAL
admet-2338	176	5	687-702 694	QUANTITY
admet-2338	176	6	3	CARDINAL
admet-2338	176	7	mg sfn-ssd	PERSON
admet-2338	176	8	sfn	CARDINAL
admet-2338	176	9	456.5	CARDINAL
admet-2338	176	10	100	CARDINAL
admet-2338	176	11	100.0	CARDINAL
admet-2338	176	12	20.0 20.0	QUANTITY
admet-2338	176	13	0.0 356.5	QUANTITY
admet-2338	176	14	10.0 10.0	QUANTITY
admet-2338	176	15	5.0 5.0	CARDINAL
admet-2338	176	16	5.0 5.0	CARDINAL
admet-2338	176	17	506.5 506.5	CARDINAL
admet-2338	178	1	3	CARDINAL
admet-2338	178	2	3d	CARDINAL
admet-2338	179	1	0.05	CARDINAL
admet-2338	179	2	150 mg	QUANTITY
admet-2338	179	3	sfn	CARDINAL
admet-2338	180	1	150 mg	QUANTITY
admet-2338	182	1	25 mg	QUANTITY
admet-2338	182	2	15 mg	QUANTITY
admet-2338	184	1	25 mg	QUANTITY
admet-2338	184	2	5	CARDINAL
admet-2338	184	3	3	CARDINAL
admet-2338	184	4	sfn	CARDINAL
admet-2338	186	1	265	CARDINAL
admet-2338	186	2	jasco	GPE
admet-2338	186	3	japan	GPE
admet-2338	187	1	4	CARDINAL
admet-2338	188	1	3224.96	CARDINAL
admet-2338	188	2	the nh group	ORG
admet-2338	188	3	1601.59	CARDINAL
admet-2338	188	4	1182	CARDINAL
admet-2338	190	1	30,31	CARDINAL
admet-2338	191	1	o	DATE
admet-2338	191	2	1602	CARDINAL
admet-2338	192	1	12(4	CARDINAL
admet-2338	192	2	2024	CARDINAL
admet-2338	192	3	687-702	QUANTITY
admet-2338	192	4	neusilin us2	PERSON
admet-2338	192	5	https://doi.org/10.5599/admet.2338 695	PERSON
admet-2338	193	1	o	DATE
admet-2338	194	1	sfn	GPE
admet-2338	194	2	3000	CARDINAL
admet-2338	194	3	2500	CARDINAL
admet-2338	196	1	32,33	CARDINAL
admet-2338	197	1	4	CARDINAL
admet-2338	197	2	ftir	ORG
admet-2338	197	3	neusilin us2	PERSON
admet-2338	198	1	5	CARDINAL
admet-2338	199	1	2 /	TIME
admet-2338	200	1	5	CARDINAL
admet-2338	201	1	neusilin us2	PERSON
admet-2338	201	2	d. sfn	PERSON
admet-2338	201	3	2	CARDINAL
admet-2338	201	4	17.9	CARDINAL
admet-2338	201	5	20.03	CARDINAL
admet-2338	201	6	21.7	CARDINAL
admet-2338	201	7	26.04°	QUANTITY
admet-2338	201	8	34	CARDINAL
admet-2338	202	1	https://doi.org/10.5599/admet.2338 b. kumar	PERSON
admet-2338	202	2	al. admet & dmpk	ORG
admet-2338	202	3	12(4	CARDINAL
admet-2338	202	4	2024	CARDINAL
admet-2338	202	5	687-702 696	QUANTITY
admet-2338	202	6	35	CARDINAL
admet-2338	204	1	6	CARDINAL
admet-2338	205	1	sfn	ORG
admet-2338	208	1	36,37	CARDINAL
admet-2338	209	1	6	CARDINAL
admet-2338	210	1	neusilin us2	PERSON
admet-2338	210	2	sfn	CARDINAL
admet-2338	211	1	7	CARDINAL
admet-2338	211	2	236.39 °	QUANTITY
admet-2338	212	1	212.84 °	QUANTITY
admet-2338	213	1	210.16 °	QUANTITY
admet-2338	213	2	-2.72	ORG
admet-2338	214	1	sfn	ORG
admet-2338	214	2	38	CARDINAL
admet-2338	216	1	0.393	CARDINAL
admet-2338	216	2	0.460 g/ml	QUANTITY
admet-2338	216	3	carr	PERSON
admet-2338	216	4	14.5 %	PERCENT
admet-2338	216	5	hausner	PERSON
admet-2338	216	6	1.17	CARDINAL
admet-2338	216	7	27.52°	QUANTITY
admet-2338	217	1	4	CARDINAL
admet-2338	217	2	weight admet & dmpk	ORG
admet-2338	217	3	12(4	CARDINAL
admet-2338	217	4	2024	CARDINAL
admet-2338	217	5	687-702	QUANTITY
admet-2338	217	6	neusilin us2	PERSON
admet-2338	217	7	697	CARDINAL
admet-2338	220	1	7	CARDINAL
admet-2338	220	2	neusilin us2	PERSON
admet-2338	220	3	4	CARDINAL
admet-2338	221	1	sfn	CARDINAL
admet-2338	221	2	5.53 ± 0.15	MONEY
admet-2338	221	3	5.83 ± 0.08	QUANTITY
admet-2338	221	4	12.03	CARDINAL
admet-2338	221	5	12.00 ± 0.00	QUANTITY
admet-2338	221	6	507.5 mg	QUANTITY
admet-2338	222	1	507.1	CARDINAL
admet-2338	222	2	0.39 ±	MONEY
admet-2338	222	3	2.87 ± 0.35	QUANTITY
admet-2338	222	4	2.27 ± 0.42	CARDINAL
admet-2338	222	5	±	CARDINAL
admet-2338	222	6	8	CARDINAL
admet-2338	223	1	97.13 %	PERCENT
admet-2338	223	2	60 min	DATE
admet-2338	224	1	sfn	CARDINAL
admet-2338	225	1	29.93 %	PERCENT
admet-2338	225	2	sfn	CARDINAL
admet-2338	226	1	ssd	ORG
admet-2338	228	1	ssd	ORG
admet-2338	228	2	sfn	CARDINAL
admet-2338	230	1	https://doi.org/10.5599/admet.2338 b. kumar	PERSON
admet-2338	230	2	al. admet & dmpk	ORG
admet-2338	230	3	12(4	CARDINAL
admet-2338	230	4	2024	CARDINAL
admet-2338	230	5	687-702 698	QUANTITY
admet-2338	230	6	17,18	CARDINAL
admet-2338	232	1	ssd	ORG
admet-2338	232	2	first	ORDINAL
admet-2338	232	3	0.9839	CARDINAL
admet-2338	234	1	30 %	PERCENT
admet-2338	234	2	1 hour	TIME
admet-2338	235	1	fda	ORG
admet-2338	235	2	0.1	CARDINAL
admet-2338	235	3	1 %	PERCENT
admet-2338	235	4	sls	ORG
admet-2338	236	1	40	CARDINAL
admet-2338	237	1	1 %	PERCENT
admet-2338	238	1	15,41	CARDINAL
admet-2338	239	1	8	CARDINAL
admet-2338	240	1	sfn	CARDINAL
admet-2338	242	1	9	CARDINAL
admet-2338	242	2	9	CARDINAL
admet-2338	244	1	±	CARDINAL
admet-2338	244	2	3	CARDINAL
admet-2338	244	3	5	CARDINAL
admet-2338	245	1	2and	CARDINAL
admet-2338	245	2	6.5	CARDINAL
admet-2338	245	3	0.01	CARDINAL
admet-2338	246	1	38,41	CARDINAL
admet-2338	247	1	12(4	CARDINAL
admet-2338	247	2	2024	CARDINAL
admet-2338	247	3	687-702	QUANTITY
admet-2338	247	4	neusilin us2	PERSON
admet-2338	247	5	699	CARDINAL
admet-2338	247	6	5	CARDINAL
admet-2338	247	7	sfn sfn	ORG
admet-2338	247	8	1.318 ±	MONEY
admet-2338	247	9	4.661 ±	MONEY
admet-2338	248	1	0.0488 ±	MONEY
admet-2338	248	2	0.0336 ± 0.0075	MONEY
admet-2338	248	3	14.83 ±	MONEY
admet-2338	248	4	0.190 ±	MONEY
admet-2338	248	5	±	CARDINAL
admet-2338	248	6	0.05	CARDINAL
admet-2338	249	1	sfn	CARDINAL
admet-2338	250	1	sfnssd	ORG
admet-2338	250	2	11	CARDINAL
admet-2338	252	1	sfn	CARDINAL
admet-2338	253	1	https://pub.iapchem.org/ojs/index.php/admet/article/view/2338	CARDINAL
admet-2338	254	1	indian	NORP
admet-2338	260	1	vidyapeeth	PERSON
admet-2338	261	1	b. kumar	PERSON
admet-2338	261	2	al. admet & dmpk	ORG
admet-2338	261	3	12(4	CARDINAL
admet-2338	261	4	2024	CARDINAL
admet-2338	261	5	687-702 700	QUANTITY
admet-2338	261	6	cipla ltd	ORG
admet-2338	261	7	mumbai	GPE
admet-2338	261	8	sfn	CARDINAL
admet-2338	262	1	aicte	NORP
admet-2338	262	2	india	GPE
admet-2338	263	1	1	CARDINAL
admet-2338	263	2	m. margaret	PERSON
admet-2338	263	3	ab	GPE
admet-2338	263	4	alkek	ORG
admet-2338	265	1	2017	CARDINAL
admet-2338	265	2	623-625	CARDINAL
admet-2338	266	1	2	CARDINAL
admet-2338	267	1	sorafenib	PERSON
admet-2338	268	1	11	CARDINAL
admet-2338	268	2	1943-1955	DATE
admet-2338	269	1	3	CARDINAL
admet-2338	269	2	f.g. foschi	ORG
admet-2338	269	3	d.e	GPE
admet-2338	269	4	matteis	ORG
admet-2338	269	5	g ercolani	PERSON
admet-2338	269	6	g.l. frassineti	GPE
admet-2338	269	7	m. scartozzi	PERSON
admet-2338	269	8	g.a. casadei	PERSON
admet-2338	270	1	ten years	DATE
admet-2338	271	1	36	CARDINAL
admet-2338	271	2	4152-4163	DATE
admet-2338	273	1	4	CARDINAL
admet-2338	273	2	d.h. truong	PERSON
admet-2338	273	3	t.h. tran	PERSON
admet-2338	273	4	t. ramasamy	PERSON
admet-2338	273	5	j.y.	GPE
admet-2338	273	6	h.g. choi	GPE
admet-2338	273	7	c.s. yong.	PERSON
admet-2338	275	1	283	CARDINAL
admet-2338	275	2	2015	CARDINAL
admet-2338	275	3	260	CARDINAL
admet-2338	277	1	5	CARDINAL
admet-2338	277	2	a. pawar	PERSON
admet-2338	277	3	c. bothiraja	PERSON
admet-2338	277	4	k. shaikh	PERSON
admet-2338	277	5	a. mali	PERSON
admet-2338	279	1	rsc advances 5 (	ORG
admet-2338	279	2	81188-81202	DATE
admet-2338	281	1	6	CARDINAL
admet-2338	281	2	a.p.	GPE
admet-2338	281	3	a.j. mali	PERSON
admet-2338	281	4	k.s. shaikh	PERSON
admet-2338	283	1	7	CARDINAL
admet-2338	283	2	2013	DATE
admet-2338	283	3	181	CARDINAL
admet-2338	285	1	t. gopan	GPE
admet-2338	285	2	e.m. remer	GPE
admet-2338	285	3	c. faiman	GPE
admet-2338	285	4	a.g. loachimescu	GPE
admet-2338	286	1	h.s. levin	PERSON
admet-2338	288	1	16	CARDINAL
admet-2338	288	2	2010	DATE
admet-2338	288	3	577	CARDINAL
admet-2338	289	1	8	CARDINAL
admet-2338	289	2	r.k.	GPE
admet-2338	289	3	k. soni	PERSON
admet-2338	289	4	a. bhattarai	PERSON
admet-2338	291	1	2023	CARDINAL
admet-2338	292	1	https://doi.org/10.3390/colloids7010016	PERSON
admet-2338	292	2	9	CARDINAL
admet-2338	293	1	22/9/2022	CARDINAL
admet-2338	293	2	10	CARDINAL
admet-2338	293	3	h. wang	PERSON
admet-2338	293	4	h. wang	PERSON
admet-2338	293	5	w. yang	PERSON
admet-2338	293	6	m. yu	PERSON
admet-2338	293	7	s. sun	PERSON
admet-2338	293	8	b. xie	PERSON
admet-2338	295	1	aaps pharmaceutics & drug delivery research	ORG
admet-2338	295	2	19	CARDINAL
admet-2338	295	3	2018	DATE
admet-2338	295	4	761	CARDINAL
admet-2338	296	1	https://doi.org/10.1208/s12249-017-0901-3	PERSON
admet-2338	297	1	11	CARDINAL
admet-2338	297	2	guo y,	PERSON
admet-2338	297	3	zhong t	PERSON
admet-2338	297	4	duan xc	PERSON
admet-2338	297	5	zhang s	PERSON
admet-2338	297	6	yin yf.	PERSON
admet-2338	298	1	24	CARDINAL
admet-2338	298	2	2017	CARDINAL
admet-2338	298	3	270	CARDINAL
admet-2338	299	1	12	CARDINAL
admet-2338	299	2	x. wang	PERSON
admet-2338	299	3	j. fan	PERSON
admet-2338	299	4	y. liu	PERSON
admet-2338	299	5	b. zhao	PERSON
admet-2338	299	6	z. jia	PERSON
admet-2338	299	7	q. zhang	PERSON
admet-2338	299	8	international journal of pharmaceutics	ORG
admet-2338	299	9	419	CARDINAL
admet-2338	299	10	2011	DATE
admet-2338	299	11	339	CARDINAL
admet-2338	300	1	13	CARDINAL
admet-2338	300	2	m.l. bondi	PERSON
admet-2338	300	3	a. scala	PERSON
admet-2338	300	4	g. sortino	PERSON
admet-2338	300	5	e. amore	PERSON
admet-2338	300	6	c. botto	PERSON
admet-2338	300	7	a. azzolina	PERSON
admet-2338	301	1	hcc	ORG
admet-2338	302	1	3784-3791	DATE
admet-2338	304	1	14	CARDINAL
admet-2338	304	2	r. a. aldeeb	PERSON
admet-2338	304	3	m. f. el-miligi	PERSON
admet-2338	304	4	m. el-nabarawi	PERSON
admet-2338	304	5	r.	NORP
admet-2338	304	6	h. m. s. amin	PERSON
admet-2338	304	7	a. a. taha	PERSON
admet-2338	306	1	pharmaceutica 90	PERSON
admet-2338	306	2	2022	CARDINAL
admet-2338	306	3	71	DATE
admet-2338	308	1	15	CARDINAL
admet-2338	308	2	k. jo	PERSON
admet-2338	308	3	j. m. cho	PERSON
admet-2338	308	4	h. lee	PERSON
admet-2338	308	5	e. k. kim	PERSON
admet-2338	308	6	h. c. kim	PERSON
admet-2338	308	7	h. kim	PERSON
admet-2338	308	8	j. lee	PERSON
admet-2338	309	1	11	CARDINAL
admet-2338	309	2	2015	CARDINAL
admet-2338	309	3	1	CARDINAL
admet-2338	310	1	https://doi.org/10.3390/colloids7010016 https://www.pharmaexcipients.com/wp-content/uploads/2020/05/technical-data-sheet_neusilin-ufl2_pharma.pdf https://www.pharmaexcipients.com/wp-content/uploads/2020/05/technical-data-sheet_neusilin-ufl2_pharma.pdf https://doi.org/10.1208/s12249-017-0901-3	PERSON
admet-2338	311	1	12(4	CARDINAL
admet-2338	311	2	2024	CARDINAL
admet-2338	311	3	687-702	QUANTITY
admet-2338	311	4	neusilin us2	PERSON
admet-2338	311	5	701	CARDINAL
admet-2338	311	6	16	CARDINAL
admet-2338	311	7	a.r.	GPE
admet-2338	313	1	359	CARDINAL
admet-2338	315	1	17	CARDINAL
admet-2338	315	2	a. mali	PERSON
admet-2338	317	1	14(8	CARDINAL
admet-2338	317	2	2023	CARDINAL
admet-2338	317	3	28	CARDINAL
admet-2338	319	1	18	CARDINAL
admet-2338	319	2	r. pandya	PERSON
admet-2338	319	3	t. mehta	PERSON
admet-2338	319	4	m. gohel.	PERSON
admet-2338	321	1	120	CARDINAL
admet-2338	321	2	2015	CARDINAL
admet-2338	321	3	699	CARDINAL
admet-2338	323	1	19	CARDINAL
admet-2338	323	2	r. censi	PERSON
admet-2338	323	3	m. r. gigliobianco	PERSON
admet-2338	323	4	a. dubbini	PERSON
admet-2338	323	5	l. malaj	PERSON
admet-2338	323	6	di martino	PERSON
admet-2338	325	1	5	CARDINAL
admet-2338	325	2	2016	CARDINAL
admet-2338	326	1	20	CARDINAL
admet-2338	326	2	x. zhang	PERSON
admet-2338	326	3	h. xing	PERSON
admet-2338	326	4	y. zhao	PERSON
admet-2338	326	5	ma	PERSON
admet-2338	327	1	10	CARDINAL
admet-2338	327	2	2018	DATE
admet-2338	327	3	74	DATE
admet-2338	328	1	21	CARDINAL
admet-2338	328	2	j. nandedkar	PERSON
admet-2338	328	3	m. masane	PERSON
admet-2338	328	4	a.j. mali	PERSON
admet-2338	330	1	6	CARDINAL
admet-2338	330	2	2020	DATE
admet-2338	330	3	253	CARDINAL
admet-2338	331	1	22	CARDINAL
admet-2338	331	2	c. liu	PERSON
admet-2338	331	3	z. chen	PERSON
admet-2338	331	4	y. chen	PERSON
admet-2338	331	5	j. lu	PERSON
admet-2338	331	6	y. li	PERSON
admet-2338	331	7	s. wang	PERSON
admet-2338	332	1	the “spring	DATE
admet-2338	333	1	13	CARDINAL
admet-2338	333	2	2016	CARDINAL
admet-2338	333	3	599	CARDINAL
admet-2338	335	1	23	CARDINAL
admet-2338	335	2	t.t. lin	PERSON
admet-2338	335	3	d.y. gao	PERSON
admet-2338	335	4	y.c. liu	PERSON
admet-2338	335	5	y.c. sung	PERSON
admet-2338	335	6	d. wan	PERSON
admet-2338	335	7	j.y. liu.	PERSON
admet-2338	336	1	221	CARDINAL
admet-2338	336	2	2016	CARDINAL
admet-2338	336	3	62	CARDINAL
admet-2338	337	1	24	CARDINAL
admet-2338	337	2	k. kostelanská	PERSON
admet-2338	337	3	b.b. prudilová	GPE
admet-2338	337	4	s. holešová s	PERSON
admet-2338	337	5	j. vlček j	ORG
admet-2338	337	6	d. vetchý	PERSON
admet-2338	337	7	j. gajdziok	PERSON
admet-2338	339	1	14	CARDINAL
admet-2338	339	2	2022	CARDINAL
admet-2338	339	3	818	CARDINAL
admet-2338	340	1	25	CARDINAL
admet-2338	340	2	a. shah	PERSON
admet-2338	341	1	serajuddin	PERSON
admet-2338	342	1	international journal of pharmaceutics 484 (	ORG
admet-2338	342	2	2015	CARDINAL
admet-2338	342	3	172	CARDINAL
admet-2338	343	1	26	CARDINAL
admet-2338	343	2	c.a. bondi	PERSON
admet-2338	343	3	l.b. wroblewski	GPE
admet-2338	343	4	h.s.	GPE
admet-2338	343	5	s.r.	GPE
admet-2338	343	6	lenox	GPE
admet-2338	343	7	k.e	DATE
admet-2338	343	8	gebhardt	PERSON
admet-2338	344	1	sls	ORG
admet-2338	345	1	9 (	PERCENT
admet-2338	345	2	27	CARDINAL
admet-2338	347	1	27	CARDINAL
admet-2338	347	2	m. shafiee panah	PERSON
admet-2338	349	1	iranian	NORP
admet-2338	349	2	21	CARDINAL
admet-2338	349	3	2022	CARDINAL
admet-2338	350	1	https://doi:10.5812	GPE
admet-2338	350	2	28	CARDINAL
admet-2338	350	3	a. mali	PERSON
admet-2338	350	4	s. rajalakshmi	ORG
admet-2338	350	5	a.p pawar	PERSON
admet-2338	350	6	c. bothiraja	PERSON
admet-2338	352	1	1(2	CARDINAL
admet-2338	352	2	2014	DATE
admet-2338	352	3	025405	DATE
admet-2338	353	1	29	CARDINAL
admet-2338	353	2	a. akram	PERSON
admet-2338	353	3	m. irfan	PERSON
admet-2338	353	4	w.a	GPE
admet-2338	353	5	abualsunun	PERSON
admet-2338	353	6	d.m.	GPE
admet-2338	354	1	bukhary	GPE
admet-2338	354	2	m. alissa	PERSON
admet-2338	355	1	irbesartan	ORG
admet-2338	356	1	14	CARDINAL
admet-2338	356	2	2022	CARDINAL
admet-2338	356	3	2264	DATE
admet-2338	357	1	https://doi.org/10.3390/pharmaceutics14112264	PERSON
admet-2338	357	2	30	CARDINAL
admet-2338	357	3	j hamidu	PERSON
admet-2338	357	4	u.o.	GPE
admet-2338	357	5	o.a. osha	PERSON
admet-2338	358	1	muhammad	PERSON
admet-2338	360	1	8	CARDINAL
admet-2338	360	2	2021	CARDINAL
admet-2338	360	3	7	CARDINAL
admet-2338	362	1	31	CARDINAL
admet-2338	362	2	krishna reddy	PERSON
admet-2338	362	3	d. kalpana	PERSON
admet-2338	364	1	asian	NORP
admet-2338	364	2	10	CARDINAL
admet-2338	364	3	2020	DATE
admet-2338	364	4	38	CARDINAL
admet-2338	365	1	32	CARDINAL
admet-2338	365	2	a. yeardley	PERSON
admet-2338	365	3	g. bagnato	PERSON
admet-2338	365	4	a. sanna	PERSON
admet-2338	367	1	26	CARDINAL
admet-2338	367	2	2021	CARDINAL
admet-2338	367	3	827	CARDINAL
admet-2338	368	1	https://doi.org/10.5599/admet.2338 https://doi.org/10.34172/apb.2020.044 https://doi.org/10.55218/jasr.202314805	PERSON
admet-2338	369	1	https://doi.org/10.3390/pharmaceutics14112264	GPE
admet-2338	369	2	b. kumar	PERSON
admet-2338	369	3	al. admet & dmpk	ORG
admet-2338	369	4	12(4	CARDINAL
admet-2338	369	5	2024	CARDINAL
admet-2338	369	6	687-702 702	QUANTITY
admet-2338	370	1	33	CARDINAL
admet-2338	370	2	pandya	PERSON
admet-2338	370	3	t.a. mehta	PERSON
admet-2338	370	4	m.c.	PERSON
admet-2338	372	1	6 (	PERCENT
admet-2338	372	2	4236-4242	DATE
admet-2338	373	1	https://doi.org/10.13040/ijpsr.0975-8232.6(10).4236-42	ORG
admet-2338	373	2	34	CARDINAL
admet-2338	373	3	a.r.	GPE
admet-2338	375	1	359	CARDINAL
admet-2338	377	1	35	CARDINAL
admet-2338	377	2	a. stasiłowicz	PERSON
admet-2338	377	3	a. miklaszewski	PERSON
admet-2338	377	4	k. lewandowska	PERSON
admet-2338	377	5	j. cielecka-piontek	PERSON
admet-2338	379	1	13	CARDINAL
admet-2338	379	2	2021	CARDINAL
admet-2338	379	3	384	CARDINAL
admet-2338	380	1	36	CARDINAL
admet-2338	380	2	m. rao	PERSON
admet-2338	380	3	k. thanki	PERSON
admet-2338	380	4	s. bhise	PERSON
admet-2338	381	1	simvastatin	ORG
admet-2338	382	1	17	CARDINAL
admet-2338	382	2	2020	DATE
admet-2338	382	3	27	CARDINAL
admet-2338	383	1	37	CARDINAL
admet-2338	383	2	t. kiran	PERSON
admet-2338	383	3	nalini shastri	PERSON
admet-2338	383	4	sistla ramakrishna	ORG
admet-2338	383	5	m. sadanandam	PERSON
admet-2338	385	1	1	CARDINAL
admet-2338	385	2	2009	DATE
admet-2338	385	3	822	CARDINAL
admet-2338	386	1	38	CARDINAL
admet-2338	386	2	mali	GPE
admet-2338	386	3	a. rokade	PERSON
admet-2338	386	4	r. kamble	PERSON
admet-2338	388	1	bionanosci 11	DATE
admet-2338	388	2	2021	CARDINAL
admet-2338	388	3	32	CARDINAL
admet-2338	390	1	asian journal of pharmaceutics	ORG
admet-2338	390	2	9 (	PERCENT
admet-2338	390	3	2015	CARDINAL
admet-2338	390	4	283	CARDINAL
admet-2338	392	1	39	CARDINAL
admet-2338	392	2	i. choi	PERSON
admet-2338	392	3	s.y. park	GPE
admet-2338	392	4	s.w	GPE
admet-2338	392	5	lee	PERSON
admet-2338	392	6	z. kang	PERSON
admet-2338	392	7	y. s. jin	PERSON
admet-2338	392	8	i. w. kim	PERSON
admet-2338	394	1	75	CARDINAL
admet-2338	394	2	2020	DATE
admet-2338	394	3	13	CARDINAL
admet-2338	395	1	40	CARDINAL
admet-2338	395	2	s. vaithianathan	PERSON
admet-2338	395	3	s.h haidar	PERSON
admet-2338	395	4	x. zhang	PERSON
admet-2338	395	5	w. jiang	PERSON
admet-2338	395	6	c. avon	PERSON
admet-2338	395	7	t.c. dowling	GPE
admet-2338	396	1	3	CARDINAL
admet-2338	397	1	105	CARDINAL
admet-2338	397	2	2016	CARDINAL
admet-2338	397	3	996	CARDINAL
admet-2338	398	1	https://doi.org/10.1002/jps.24643	NORP
admet-2338	398	2	2024	CARDINAL
admet-2338	398	3	iapc	ORG
admet-2338	398	4	zagreb	GPE
admet-2338	398	5	croatia	GPE
admet-2338	399	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-2338	399	2	https://doi.org/10.3390/pharmaceutics13030384	NORP
admet-2338	400	1	https://doi.org/10.1002/jps.24643	NORP